SCHEMBL8970922

SCHEMBL8970922

CC(=O)Oc1ccc2c(c1)C[C@@H](C)[C@@H]1[C@@H]2[C@@H](O[N+](=O)[O-])C[C@]2(C)[C@@H](O[N+](=O)[O-])CC[C@@H]12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
MAPT P10636 2/20 0.41
CYP3A4 P08684 2/20 0.41
TP53 P04637 1/20 0.41
OPRM1 P35372 4/20 0.38
ESR1 P03372 3/20 0.38
ADORA3 P0DMS8 2/20 0.38
LMNA P02545 2/20 0.38
PGR P06401 1/20 0.38
AR P10275 1/20 0.38
CHRM1 P11229 1/20 0.38
TBXA2R P21731 1/20 0.38
ADRA1A P35348 1/20 0.38
SLC6A3 Q01959 1/20 0.38
ATM Q13315 1/20 0.38
KMT2A Q03164 3/20 0.33
MEN1 O00255 2/20 0.33
THRB P10828 1/20 0.33
HRH3 Q9Y5N1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8775742 0.76 ESR1 (0.52) AKR1C3SMN1; SMN2MAPTCYP3A4TP53
SCHEMBL7029732 0.74 ESR1 (0.45) AKR1C3SMN1; SMN2MAPTCYP3A4TP53
SCHEMBL5679460 0.70 AKR1C3 (0.58) AKR1C3SMN1; SMN2MAPTCYP3A4TP53
SCHEMBL9111396 0.70 AKR1C3 (0.81) AKR1C3SMN1; SMN2MAPTCYP3A4TP53
SCHEMBL8775736 0.70 HSD17B10 (0.52) AKR1C3SMN1; SMN2MAPTCYP3A4TP53
SCHEMBL10356258 0.70 HSD17B10 (0.52) AKR1C3SMN1; SMN2MAPTCYP3A4TP53
SCHEMBL24102655 0.69 CYP3A4 (0.53) AKR1C3SMN1; SMN2MAPTCYP3A4TP53
SCHEMBL25863718 0.69 CYP3A4 (0.53) AKR1C3SMN1; SMN2MAPTCYP3A4TP53
SCHEMBL13475526 0.69 CYP3A4 (0.53) AKR1C3SMN1; SMN2MAPTCYP3A4TP53
SCHEMBL8775995 0.69 AKR1C3 (0.58) AKR1C3SMN1; SMN2MAPTCYP3A4TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5554603-A 11,17-DINITRATES; USE TO ACHIEVE ESTROGENIC EFFECT IN FEMALE MAMMALS THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1996-09-10 US disclosed